Dr. Luis Zuniga-Montes, M.D.
What this data tells you about Dr. Zuniga-Montes
Dr. Luis Zuniga-Montes is a rheumatology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zuniga-Montes performed 11,783 Medicare services across 3,933 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zuniga-Montes received a total of $11,112 from 36 pharmaceutical and/or device companies across 858 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zuniga-Montes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,062 | $18 | $29 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 1,632 | $17 | $49 |
| Office visit, established patient (30-39 min) | 905 | $90 | $210 |
| Blood draw (venipuncture) | 727 | $6 | $6 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 670 | $4 | $10 |
| Comprehensive metabolic blood panel | 668 | $10 | $29 |
| C-reactive protein test (inflammation marker) | 667 | $5 | $14 |
| Complete blood count (CBC) with differential | 653 | $8 | $21 |
| Measurement of complement (immune system proteins), antigen, | 230 | $12 | $33 |
| Analysis of substance using immunoassay technique, multiple step method | 220 | $11 | $40 |
| Measurement of dna antibody, native or double stranded | 204 | $13 | $38 |
| X-ray of hand, 2 views | 179 | $23 | $53 |
| Vitamin D level test | 165 | $29 | $74 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 141 | $56 | $136 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 129 | $79 | $178 |
| Injection of additional new drug or substance into vein | 111 | $12 | $42 |
| Rheumatoid factor level | 110 | $6 | $16 |
| Screening test for autoimmune disorder | 109 | $12 | $33 |
| Manual urinalysis test with examination using microscope, non-automated | 108 | $4 | $9 |
| Measurement of antibody for rheumatoid arthritis assessment | 107 | $13 | $36 |
| Administration of chemotherapy into vein, 1 hour or less | 102 | $97 | $246 |
| Bone density scan (DEXA) | 93 | $37 | $92 |
| X-ray of foot, 2 views | 81 | $22 | $50 |
| Injection, methylprednisolone acetate, 80 mg | 74 | $9 | $26 |
| X-ray of knee, 1-2 views | 72 | $26 | $59 |
| Measurement of antibody for assessment of autoimmune disorder, titer | 69 | $11 | $28 |
| Creatine kinase (cardiac enzyme) level, total | 67 | $6 | $18 |
| New patient office visit (45-59 min) | 64 | $118 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 61 | $1 | $20 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 44 | $58 | $183 |
| Flu vaccine administration | 39 | $30 | $40 |
| Uric acid level test | 37 | $4 | $12 |
| Tuberculosis test, gamma interferon | 36 | $61 | $153 |
| Flu vaccine, quadrivalent | 34 | $76 | $100 |
| Office visit, established patient (20-29 min) | 33 | $55 | $142 |
| Drug injection, under skin or into muscle | 27 | $11 | $30 |
| Thyroid stimulating hormone (TSH) test | 21 | $16 | $46 |
| Drug screening test | 19 | $58 | $122 |
| Parathyroid hormone level test | 13 | $40 | $113 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zuniga-Montes is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zuniga-Montes experienced with denosumab injection (prolia/xgeva)?
Does Dr. Zuniga-Montes receive payments from pharmaceutical companies?
How do Dr. Zuniga-Montes's costs compare to other rheumatologists in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology